Nektar Therapeutics
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $437.7M | $1.12B | $25.2M |
| FY2022 | $344.0M | $710.6M | $88.2M |
| FY2023 | $267.0M | $398.0M | $35.3M |
| FY2024 | $243.1M | $303.9M | $44.3M |
| FY2025 | $190.6M | $280.4M | $15.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $437.7M | $1.12B | $25.2M |
| FY2022 | $344.0M | $710.6M | $88.2M |
| FY2023 | $267.0M | $398.0M | $35.3M |
| FY2024 | $243.1M | $303.9M | $44.3M |
| FY2025 | $190.6M | $280.4M | $15.1M |